STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
115
13F, latest reported quarter
Conversions, 180 days
2
Codes C/M, not in net · $2.9M priced
What the filings say about SCSC
Insiders, 180 days
-$5.5M net sold
4 sellers · 0% of sales under a 10b5-1 plan
Planned sales (Form 144), 90 days
$7.1M
6 notices
Scansource insider trades (Form 4)
Form 4 buys and sells (codes P and S). Grants, option exercises
and conversions excluded.
Over the last 180 days, SCANSOURCE, INC. insiders sold a net $5.5M of stock across 91 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-27.
5 earlier Form 4 trades (code P or S) here by this insider (3 buys, 2 sales), the last on Feb 11, 2026.
+6.7% median (+6.7% mean) 90-day return after 2 previous buys.
The trade is 12.0% of the 25,027 shares held after it.
3 other insiders sold within 30 days.
115 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Mathis Charles Alexander sold about $174.0K of SCSC on Sep 11, 2026; 3 other insiders sold within 30 days and 115 funds added in the latest 13F quarter.
52 earlier Form 4 trades (code P or S) here by this insider (52 sales), the last on Sep 10, 2026.
The trade is 0.7% of the 256,206 shares held after it.
3 other insiders sold within 30 days.
115 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO, President, BOD Chair BAUR MICHAEL L sold about $104.6K of SCSC on Sep 11, 2026; 3 other insiders sold within 30 days and 115 funds added in the latest 13F quarter.
52 earlier Form 4 trades (code P or S) here by this insider (52 sales), the last on Sep 10, 2026.
The trade is 2.7% of the 249,514 shares held after it.
3 other insiders sold within 30 days.
115 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO, President, BOD Chair BAUR MICHAEL L sold about $386.2K of SCSC on Sep 11, 2026; 3 other insiders sold within 30 days and 115 funds added in the latest 13F quarter.
52 earlier Form 4 trades (code P or S) here by this insider (52 sales), the last on Sep 10, 2026.
The trade is 24.3% of the 200,698 shares held after it.
3 other insiders sold within 30 days.
115 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO, President, BOD Chair BAUR MICHAEL L sold about $2.8M of SCSC on Sep 11, 2026; 3 other insiders sold within 30 days and 115 funds added in the latest 13F quarter.
50 earlier Form 4 trades (code P or S) here by this insider (50 sales), the last on Mar 16, 2026.
The trade is 8.9% of the 202,598 shares held after it.
3 other insiders sold within 30 days.
115 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: CEO, President, BOD Chair BAUR MICHAEL L sold about $1.0M of SCSC on Sep 10, 2026; 3 other insiders sold within 30 days and 115 funds added in the latest 13F quarter.
91 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
SCSC planned insider sales (Form 144)
Notice of intent to sell, filed before any sale
BAUR MICHAEL L
Filed 2026-09-11
$3.3M
Mathis Charles Alexander
Filed 2026-09-11
$174.0K
BAUR MICHAEL L
Filed 2026-09-10
$1.1M
Ford Brandy
Filed 2026-09-04
$304.0K
Jones Stephen
Filed 2026-09-03
$567.6K
SCSC mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
ICON HEALTH AND INFORMATION TECHNOLOGY FUND
$5.2M position · as of 2026-06-30
5.3%
JAMES MICRO CAP FUND
$676.3K position · as of 2026-06-30
2.1%
Pzena Small Cap Value Fund
$1.9M position · as of 2026-05-31
2.0%
Wasatch Small Cap Value Fund
$23.6M position · as of 2026-06-30
1.7%
JPMorgan Active Small Cap Value ETF
$432.2K position · as of 2026-06-30
1.6%
ETC 6 Meridian Small Cap Equity ETF
$1.7M position · as of 2026-05-31
1.4%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return · Mike Baur
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2024
$8.2M
$6.7M
$1.8M
+74%
+87%
2023
$5.9M
$7.7M
$1.8M
+84%
+63%
2022
$5.7M
$5.2M
$1.8M
+23%
+59%
2021
$5.6M
$7.3M
$2.1M
+29%
+30%
2020
$6.6M
$7.6M
$1.4M
+17%
+68%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $5.5M sold by insiders over 180 days, 115 funds added last quarter, $7.1M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$3.2B
four quarters, 2025-07-01 to 2026-06-30
Revenue, TTM SCSC
FY Jun 2026
$3.2B
FY Jun 2025
$3.0B
FY Jun 2024
$3.3B
FY Jun 2023
$3.8B
FY Jun 2022
$3.5B
Jun 2026
$953.1M
Mar 2026
$766.8M
Dec 2025
$766.5M
Sep 2025
$739.6M
Jun 2025
$812.9M
Mar 2025
$704.8M
Dec 2024
$747.5M
Sep 2024
$775.6M
At each fiscal year end
Single quarter
Net margin, TTM
+2.4%
net income over revenue, 2025-07-01 to 2026-06-30
Net margin, TTM SCSC
FY Jun 2026
+2.4%
FY Jun 2025
+2.4%
FY Jun 2024
+2.4%
FY Jun 2023
+2.4%
FY Jun 2022
+2.5%
Jun 2026
+2.7%
Mar 2026
+2.2%
Dec 2025
+2.2%
Sep 2025
+2.7%
Jun 2025
+2.5%
Mar 2025
+2.5%
Dec 2024
+2.3%
Sep 2024
+2.2%
At each fiscal year end
Single quarter
Free cash flow, TTM
$113.8M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM SCSC
FY Jun 2026
$113.8M
FY Jun 2025
$104.1M
FY Jun 2024
$363.1M
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
-$4.8M
Mar 2026
$69.0M
Dec 2025
$28.9M
Sep 2025
$20.8M
Jun 2025
$5.1M
Mar 2025
$64.6M
Dec 2024
-$8.2M
Sep 2024
$42.5M
At each fiscal year end
Single quarter
Debt to equity
0.11x
long-term 2026-06-30 plus current 2026-06-30; equity 2026-06-30
Debt to equity SCSC
FY Jun 2026
0.11x
FY Jun 2025
0.15x
FY Jun 2024
0.16x
FY Jun 2023
0.17x
FY Jun 2022
0.17x
Jun 2026
0.11x
Mar 2026
0.11x
Dec 2025
0.11x
Sep 2025
0.15x
Jun 2025
0.15x
Mar 2025
0.15x
Dec 2024
0.16x
Sep 2024
0.16x
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
1.21x
TTM operating cash flow over long-term 2026-06-30 plus current 2026-06-30
Cash flow to debt SCSC
FY Jun 2026
1.21x
FY Jun 2025
0.83x
FY Jun 2024
2.58x
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
1.21x
Mar 2026
1.30x
Dec 2025
1.24x
Sep 2025
0.68x
Jun 2025
0.83x
Mar 2025
1.16x
Dec 2024
1.81x
Sep 2024
2.25x
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+8.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity SCSC
FY Jun 2026
+8.7%
FY Jun 2025
+7.8%
FY Jun 2024
+8.4%
FY Jun 2023
+10.5%
FY Jun 2022
+11.5%
Jun 2026
+8.7%
Mar 2026
+8.1%
Dec 2025
+8.2%
Sep 2025
+8.1%
Jun 2025
+7.8%
Mar 2025
+7.3%
Dec 2024
+6.8%
Sep 2024
+8.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+4.2%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets SCSC
FY Jun 2026
+4.2%
FY Jun 2025
+4.0%
FY Jun 2024
+4.0%
FY Jun 2023
+4.5%
FY Jun 2022
+4.9%
Jun 2026
+4.2%
Mar 2026
+4.2%
Dec 2025
+4.3%
Sep 2025
+4.3%
Jun 2025
+4.0%
Mar 2025
+3.9%
Dec 2024
+3.6%
Sep 2024
+4.3%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
+8.3%
operating income after a 24.0% effective tax rate, over long-term 2026-06-30 plus current 2026-06-30 plus average of 2025-06-30 and 2026-06-30 minus cash
Return on invested capital SCSC
FY Jun 2026
+8.3%
FY Jun 2025
+7.2%
FY Jun 2024
+7.4%
FY Jun 2023
+10.1%
FY Jun 2022
+10.7%
Jun 2026
+8.3%
Mar 2026
+8.0%
Dec 2025
+7.7%
Sep 2025
+7.7%
Jun 2025
+7.2%
Mar 2025
+6.7%
Dec 2024
+5.8%
Sep 2024
+6.6%
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
+9.1%
operating income (EBIT proxy) over average of 2025-06-30 and 2026-06-30 minus current liabilities
Return on capital employed SCSC
FY Jun 2026
+9.1%
FY Jun 2025
+7.7%
FY Jun 2024
+7.6%
FY Jun 2023
+11.3%
FY Jun 2022
+11.8%
Jun 2026
+9.1%
Mar 2026
+8.7%
Dec 2025
+8.6%
Sep 2025
+8.4%
Jun 2025
+7.7%
Mar 2025
+7.2%
Dec 2024
+6.7%
Sep 2024
+7.2%
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
16.77x
close 2026-10-23 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing SCSC
FY Jun 2026
14.31x
FY Jun 2025
13.94x
FY Jun 2024
14.53x
FY Jun 2023
8.37x
FY Jun 2022
9.03x
Jun 2026
14.31x
Mar 2026
11.03x
Dec 2025
12.02x
Sep 2025
13.75x
Jun 2025
13.94x
Mar 2025
12.23x
Dec 2024
18.68x
Sep 2024
15.35x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
$1.2B
market value at close 2026-10-23 on 2026-08-17 shares, plus long-term 2026-06-30 plus current 2026-06-30, minus cash 2026-06-30
Enterprise value SCSC
FY Jun 2026
$1.1B
FY Jun 2025
$954.7M
FY Jun 2024
$1.1B
FY Jun 2023
$850.8M
FY Jun 2022
$883.1M
Jun 2026
$1.1B
Mar 2026
$761.5M
Dec 2025
$876.3M
Sep 2025
$971.7M
Jun 2025
$954.7M
Mar 2025
$789.7M
Dec 2024
n/a
Sep 2024
$1.2B
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+9.3%
TTM free cash flow over market value at close 2026-10-23
FCF yield SCSC
FY Jun 2026
+10.8%
FY Jun 2025
+11.0%
FY Jun 2024
+33.2%
FY Jun 2023
n/a
FY Jun 2022
n/a
Jun 2026
+10.8%
Mar 2026
+15.9%
Dec 2025
+13.9%
Sep 2025
+8.6%
Jun 2025
+11.0%
Mar 2025
+19.1%
Dec 2024
n/a
Sep 2024
+27.2%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
0.79x
P/E over trailing EPS growth of 21%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing SCSC
FY Jun 2026
0.67x
FY Jun 2025
n/a
FY Jun 2024
n/a
FY Jun 2023
3.61x
FY Jun 2022
0.01x
Jun 2026
0.67x
Mar 2026
0.60x
Dec 2025
0.43x
Sep 2025
6.15x
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-23. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
SCSC ranks highest on financial health (76th percentile) and risk and compliance (75th), and lowest on insider conviction (14th), among Wholesale & Retail peers.
Profitability
47
Inputs
Return on equity+8.7% · 51 pct, sector of 206
Return on assets+4.2% · 62 pct, sector of 257
Return on invested capital+8.3% · 22 pct, sector of 109
Return on capital employed+9.1% · 53 pct, sector of 220
Financial health
76
Inputs
Debt to equity0.11x · 70 pct, sector of 222
Cash flow to debt1.21x · 82 pct, sector of 210
Growth
59
Inputs
Revenue growth, YoY+6.1% · 59 pct, sector of 311
Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
14
Inputs
Net Form 4 buying (codes P and S), 180d-$5.5M · 27 pct, sector of 187
Insider buyers, 180d0 · 0 pct, sector of 189
Institutional and government
53
Inputs
Funds adding, latest quarter115 · 53 pct, sector of 234
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
75
Inputs
Short interest, % of float+5.2% · 49 pct, sector of 320
Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
EPA cases per $1B revenue, 5y0.00 per $1B · 100 pct, sector of 242
New text in Risk Factors, latest 10-K+6.0% · 77 pct, sector of 226
1 not measured: US patents
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
SCSC filings, in plain words
Are Scansource insiders buying or selling SCSC?
In the 180 days to 2026-10-27, Scansource insiders were net sellers, a net $5.5M across purchases and sales reported on Form 4, by 4 sellers.
Are there planned insider sales of SCSC?
Yes. 6 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-27, covering $7.1M of stock; the latest, by BAUR MICHAEL L, was filed 2026-09-11.
Read the full summary
In the 180 days to 2026-10-27, Scansource insiders were net sellers of SCSC, a net $5.5M across purchases and sales reported on Form 4 by 4 sellers. None of the 10 insider sales was flagged as made under a Rule 10b5-1 plan. Insiders filed 6 Form 144 notices of intent to sell in the 90 days to 2026-10-27, covering $7.1M of stock. Each figure is counted from SEC and House filings as of 2026-10-27, dated the day the filing was made public.
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.